Adverse events and tolerability of combined durvalumab and tremelimumab versus durvalumab alone in solid cancers: a systematic review and meta-analysis

Adverse events and tolerability of combined durvalumab and tremelimumab versus durvalumab alone in solid cancers: a systematic review and meta-analysis

Background: Recently, the combination of durvalumab and tremelimumab, two immune checkpoint inhibitors, for the treatment of different types of cancers has been considered; however, its overall effects, including its safety, are still unclear and need to be further investigated. Objectives: The aim...

Full description

Saved in:
Bibliographic Details
Main Authors: Fahmy, Omar, Ahmed, Osama A. A., Khairul-Asri, Mohd Ghani, Alhakamy, Nabil A., Alharbi, Waleed S., Fahmy, Usama A., El-Moselhy, Mohamed A., Fresta, Claudia G., Caruso, Giuseppe, Caraci, Filippo
Format: Article
Published: Multidisciplinary Digital Publishing Institute 2022
Online Access:http://psasir.upm.edu.my/id/eprint/100141/
https://www.mdpi.com/2227-9059/10/5/1101
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universiti Putra Malaysia

Internet

http://psasir.upm.edu.my/id/eprint/100141/
https://www.mdpi.com/2227-9059/10/5/1101

Similar Items